Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.008 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2001Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic jointHaynes, D.; Crotti, T.; Loric, M.; Bain, G.; Atkins, G.; Findlay, D.
2005Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free mediumAtkins, G.; Kostakis, P.; Welldon, K.; Vincent, C.; Findlay, D.; Zannettino, A.
2001The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysisHaynes, D.; Crotti, T.; Potter, A.; Loric, M.; Atkins, G.; Howie, D.; Findlay, D.
1999Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formationHaynes, D.; Atkins, G.; Loric, M.; Crotti, T.; Geary, S.; Findlay, D.
2010Osteoclastic metabolism of 25(OH)-vitamin D-3: A potential mechanism for optimization of bone resorptionKogawa, M.; Findlay, D.; Anderson, P.; Ormsby, R.; Vincent, C.; Morris, H.; Atkins, G.
2008Does Apo2LTRAIL play any physiologic role in osteoclastogenesis?Labrinidis, A.; Liapis, V.; Thai, L.; Atkins, G.; Vincent, C.; Hay, S.; Sims, N.; Zannettino, A.; Findlay, D.; Evdokiou, A.
2009Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myelomaLabrinidis, A.; Diamond, P.; Martin, S.; Hay, S.; Liapis, V.; Zinonos, I.; Sims, N.; Atkins, G.; Vincent, C.; Ponomarev, V.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2000Expression of osteoclast differentiation signals by stromal elements of giant cell tumorsAtkins, G.; Haynes, D.; Graves, S.; Evdokiou, A.; Hay, S.; Bouralexis, S.; Findlay, D.
2011Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathwayWijenayaka, A.; Kogawa, M.; Lim, H.; Bonewald, L.; Findlay, D.; Atkins, G.; Carvalho, D.P.D.